PETAL & MGH - Our Foundation
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School and a founding member of Mass General Brigham.
Ranked among the top hospitals on the U.S. News & World Report Best Hospitals Honor Roll for 2024–2025, Mass General leads global innovation in patient care, education, and research.
As part of Mass General Brigham, our research is embedded in a world-class academic and clinical ecosystem, propelling PETAL's mission forward with scientific rigor and collaborative strength.
Our Mission
Changing the future of T-cell lymphoma, one discovery at a time
At PETAL, we are dedicated to improving the lives of people affected by T-cell lymphoma. Through global collaboration and cutting-edge research, we uncover better ways to diagnose, treat, and predict outcomes—ensuring that every patient has access to the most effective care possible.
Our History & Vision
Founded in Innovation
Established in 2023, the PETAL Consortium brings together a global network of clinicians, researchers, and data scientists focused on transforming T-cell lymphoma care through genomics, machine learning, and clinical trials.
Rooted in Collaboration
Built on the expertise of both Massachusetts General Hospital and Harvard Medical School, PETAL consortium team thrives through a dynamic international collaboration and an unwavering commitment to precision medicine.
Evolving with Purpose
With a multidisciplinary leadership team and growing partnerships across academia and industry, PETAL is accelerating discoveries, advancing treatment strategies, and shaping the future of T-cell lymphoma care.
